Gasior M., Bergman J., Kallman M.J., Paronis C.A. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys (англ.) // Neuropsychopharmacology[англ.] : journal. — Nature Publishing Group, 2005. — April (vol. 30, no. 4). — P. 758—764. — doi:10.1038/sj.npp.1300593. — PMID15526000.
Prasad S., Steer C. Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder : clinical approaches and review of current available evidence (англ.) // Paediatric Drugs : journal. — 2008. — Vol. 10, no. 1. — P. 39—47. — doi:10.2165/00148581-200810010-00005. — PMID18162007.
Pilhatsch M.K., Burghardt R., Wandinger K.P., Bauer M., Adli M. Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report (англ.) // Pharmacopsychiatry : journal. — 2006. — March (vol. 39, no. 2). — P. 79—80. — doi:10.1055/s-2006-931547. — PMID16555170.
Carpenter L.L., Milosavljevic N., Schecter J.M., Tyrka A.R., Price L.H. Augmentation with open-label atomoxetine for partial or nonresponse to antidepressants (англ.) // The Journal of Clinical Psychiatry[англ.] : journal. — 2005. — October (vol. 66, no. 10). — P. 1234—1238. — doi:10.4088/JCP.v66n1005. — PMID16259536.
«STRATTERA® (atomoxetine hydrochloride) CAPSULES for Oral Use, Full Prescribing Information». Eli Lilly and Company, 2002. Revised August 22, 2012. [1]Архивная копия от 9 июля 2014 на Wayback Machine
Gasior M., Bergman J., Kallman M.J., Paronis C.A. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys (англ.) // Neuropsychopharmacology[англ.] : journal. — Nature Publishing Group, 2005. — April (vol. 30, no. 4). — P. 758—764. — doi:10.1038/sj.npp.1300593. — PMID15526000.
Prasad S., Steer C. Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder : clinical approaches and review of current available evidence (англ.) // Paediatric Drugs : journal. — 2008. — Vol. 10, no. 1. — P. 39—47. — doi:10.2165/00148581-200810010-00005. — PMID18162007.
Pilhatsch M.K., Burghardt R., Wandinger K.P., Bauer M., Adli M. Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report (англ.) // Pharmacopsychiatry : journal. — 2006. — March (vol. 39, no. 2). — P. 79—80. — doi:10.1055/s-2006-931547. — PMID16555170.
Carpenter L.L., Milosavljevic N., Schecter J.M., Tyrka A.R., Price L.H. Augmentation with open-label atomoxetine for partial or nonresponse to antidepressants (англ.) // The Journal of Clinical Psychiatry[англ.] : journal. — 2005. — October (vol. 66, no. 10). — P. 1234—1238. — doi:10.4088/JCP.v66n1005. — PMID16259536.
«STRATTERA® (atomoxetine hydrochloride) CAPSULES for Oral Use, Full Prescribing Information». Eli Lilly and Company, 2002. Revised August 22, 2012. [1]Архивная копия от 9 июля 2014 на Wayback Machine
Gasior M., Bergman J., Kallman M.J., Paronis C.A. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys (англ.) // Neuropsychopharmacology[англ.] : journal. — Nature Publishing Group, 2005. — April (vol. 30, no. 4). — P. 758—764. — doi:10.1038/sj.npp.1300593. — PMID15526000.